\-\ Texto\\:\\ \ \(0\)\
\-\ asymptomatic\\ right\\-sided\\ abdominal\\ mass\\.\ \(0\)\
\-\ 6\\ weeks\\ of\\ neoadjuvant\\ chemotherapy\\ comprised\\ of\\ vincristine\\,\\ dactinomycin\\,\\ doxorubicin\\ \\(dd4a\\)\\ followed\\ by\\ right\\ nephrectomy\\.\ \(0\)\
\-\ \\‚\\Ä\\¢\\ initial\\ study\\:\ \(0\)\
\-\ large\\ right\\-sided\\ renal\\ mass\\ \\(12\\.2cm\\ ap\\ x\\ 10\\.6cm\\ trans\\ x\\ 14\\.1cm\\ cc\\)\\.\\ predominantly\\ hypodense\\ w\\/\\ areas\\ of\\ heterogeneity\\.\\ \\ possible\\ cystic\\ degeneration\\ along\\ superior\\ border\\.\ \(0\)\
\-\ classic\\ \\‚\\Ä\\úclaw\\ sign\\‚\\Ä\\ù\\ demonstrating\\ renal\\ origination\\.\ \(0\)\
\-\ significant\\ mass\\ effect\\ on\\ liver\\,\\ pancreas\\,\\ and\\ inferior\\ vena\\ cava\\.\ \(0\)\
\-\ non\\-opacification\\ of\\ right\\ renal\\ vein\\ and\\ mass\\ effect\\ on\\ ivc\\ limit\\ evaluation\\ for\\ tumor\\ thrombosis\\.\ \(0\)\
\-\ right\\ lower\\ lobe\\ ground\\ glass\\ opacity\\ \\(3mm\\ x\\ 5mm\\)\\.\\ \\ ddx\\ includes\\ metastatic\\,\\ atelectasis\\,\\ or\\ infection\\.\ \(0\)\
\-\ \\‚\\Ä\\¢\\ after\\ 6\\ weeks\\ doxorubicin\\ \\(dd4a\\)\\ therapy\\:\ \(0\)\
\-\ decrease\\ in\\ right\\ renal\\ mass\\ size\\ \\(7\\.3cm\\ ap\\ x\\ 8\\.4cm\\ trans\\ x\\ 11\\.7cm\\ cc\\)\\.\ \(0\)\
\-\ increased\\ calcification\\ and\\ heterogenicity\\ of\\ mass\\.\ \(0\)\
\-\ continued\\ mass\\ effect\\ on\\ liver\\,\\ adjacent\\ ivc\\,\\ and\\ right\\ renal\\ vein\\.\ \(0\)\
\-\ ivc\\ and\\ right\\ renal\\ vein\\ grossly\\ patent\\.\ \(0\)\
\-\ resolution\\ of\\ previously\\ noted\\ right\\ lower\\ lobe\\ lung\\ mass\\.\ \(0\)\
\-\ internal\\ reproductive\\ organs\\ within\\ normal\\ limits\\ for\\ age\\.\ \(0\)\
\-\ wilms\\ tumor\ \(0\)\
\-\ \\‚\\Ä\\¢\\ wilms\\ tumor\ \(0\)\
\-\ \\‚\\Ä\\¢\\ neuroblastoma\ \(1\)\
\-\ \\‚\\Ä\\¢\\ multilocular\\ cystic\\ nephroma\ \(0\)\
\-\ \\‚\\Ä\\¢\\ mesoblastic\\ nephroma\ \(0\)\
\-\ \\‚\\Ä\\¢\\ renal\\ cell\\ carcinoma\ \(1\)\
\-\ 30\\ month\\ old\\ girl\\ with\\ right\\-sided\\ abdominal\\ mass\\.\ \(1\)\
\-\ this\\ case\\ demonstrates\\ the\\ classic\\ \\"claw\\ sign\\"\\ expected\\ for\\ tumor\\ originating\\ from\\ the\\ kidney\\.\\ \\ also\\ demonstrated\\ the\\ significant\\ mass\\ effect\\ that\\ wilms\\ tumors\\ can\\ have\\ on\\ intra\\-abdominal\\ organs\\ and\\ vessels\\.\\ \\ finally\\,\\ benefits\\ on\\ neoadjuvant\\ therapy\\ was\\ appreciated\\ with\\ decreased\\ tumor\\ burden\\ prior\\ to\\ tumor\\ removal\\.\ \(0\)\
\-\ Keywords\\ by\\ value\\:\\ \ \(0\)\
\-\ renal\\:\\ 0\\.2810389550275198\ \(0\)\
\-\ mass\\:\\ 0\\.24626512935083938\ \(0\)\
\-\ right\\:\\ 0\\.21375074850908998\ \(0\)\
\-\ wilms\\:\\ 0\\.21226597827005933\ \(0\)\
\-\ dd4a\\:\\ 0\\.20620894129830217\ \(0\)\
\-\ tumor\\:\\ 0\\.20233500491275416\ \(0\)\
\-\ ivc\\:\\ 0\\.18780855223314502\ \(0\)\
\-\ effect\\:\\ 0\\.18090452961184236\ \(0\)\
\-\ neoadjuvant\\:\\ 0\\.1698285879589027\ \(0\)\
\-\ claw\\:\\ 0\\.16570732139353275\ \(0\)\
\-\ nephroma\\:\\ 0\\.16389800525594939\ \(0\)\
\-\ doxorubicin\\:\\ 0\\.16066329876954616\ \(0\)\
\-\ trans\\:\\ 0\\.15783406296581773\ \(0\)\
\-\ vein\\:\\ 0\\.138637857626542\ \(0\)\
\-\ organs\\:\\ 0\\.13300060841875475\ \(0\)\
\-\ cc\\:\\ 0\\.1248939119322842\ \(0\)\
\-\ abdominal\\:\\ 0\\.10578404048797616\ \(0\)\
\-\ heterogenicity\\:\\ 0\\.10310447064915108\ \(0\)\
\-\ on\\:\\ 0\\.09735797660191284\ \(0\)\
\-\ classic\\:\\ 0\\.09644365742752489\ \(0\)\
\-\ dactinomycin\\:\\ 0\\.09527038797029787\ \(0\)\
\-\ origination\\:\\ 0\\.09527038797029787\ \(0\)\
\-\ ap\\:\\ 0\\.09257298001855023\ \(0\)\
\-\ comprised\\:\\ 0\\.0906877433756196\ \(0\)\
\-\ sign\\:\\ 0\\.08926920726661704\ \(0\)\
\-\ liver\\:\\ 0\\.08895127819351349\ \(0\)\
\-\ reproductive\\:\\ 0\\.08610509878094133\ \(0\)\
\-\ mesoblastic\\:\\ 0\\.0838370800057607\ \(0\)\
\-\ heterogeneity\\:\\ 0\\.08033164938477308\ \(0\)\
\-\ and\\:\\ 0\\.07993386972066319\ \(0\)\
\-\ burden\\:\\ 0\\.07960222261259144\ \(0\)\
\-\ multilocular\\:\\ 0\\.0782710161020881\ \(0\)\
\-\ cystic\\:\\ 0\\.07765836392113895\ \(0\)\
\-\ weeks\\:\\ 0\\.07727844935702738\ \(0\)\
\-\ vincristine\\:\\ 0\\.07600299732690749\ \(0\)\
\-\ limit\\:\\ 0\\.07600299732690749\ \(0\)\
\-\ of\\:\\ 0\\.07570109511394911\ \(0\)\
\-\ benefits\\:\\ 0\\.07455819998860484\ \(0\)\
\-\ lobe\\:\\ 0\\.07451579499896734\ \(0\)\
\-\ significant\\:\\ 0\\.07444921355329893\ \(0\)\
\-\ therapy\\:\\ 0\\.07408648041723087\ \(0\)\
\-\ 3mm\\:\\ 0\\.07212696982516398\ \(0\)\
\-\ finally\\:\\ 0\\.0695322753544432\ \(0\)\
\-\ 5mm\\:\\ 0\\.0686946928073348\ \(0\)\
\-\ originating\\:\\ 0\\.0686946928073348\ \(0\)\
\-\ lower\\:\\ 0\\.06589033766141926\ \(0\)\
\-\ nephrectomy\\:\\ 0\\.06585428882855662\ \(0\)\
\-\ glass\\:\\ 0\\.06485344130912243\ \(0\)\
\-\ ground\\:\\ 0\\.06276092593976522\ \(0\)\
\-\ hypodense\\:\\ 0\\.06260285074438168\ \(0\)\
\-\ vena\\:\\ 0\\.06229318227118374\ \(0\)\
\-\ cava\\:\\ 0\\.06199177261620546\ \(0\)\
\-\ grossly\\:\\ 0\\.061844029437475904\ \(0\)\
\-\ ddx\\:\\ 0\\.06127164423387835\ \(0\)\
\-\ pancreas\\:\\ 0\\.06059466392346768\ \(0\)\
\-\ degeneration\\:\\ 0\\.05995595205968989\ \(0\)\
\-\ neuroblastoma\\:\\ 0\\.05923429044908522\ \(0\)\
\-\ for\\:\\ 0\\.05862273863195434\ \(0\)\
\-\ patent\\:\\ 0\\.05844675459141504\ \(0\)\
\-\ expected\\:\\ 0\\.05812534357977828\ \(0\)\
\-\ appreciated\\:\\ 0\\.05812534357977828\ \(0\)\
\-\ atelectasis\\:\\ 0\\.057409128021527187\ \(0\)\
\-\ border\\:\\ 0\\.05701935863026922\ \(0\)\
\-\ predominantly\\:\\ 0\\.05645880446745753\ \(0\)\
\-\ opacity\\:\\ 0\\.05609997457603179\ \(0\)\
\-\ decrease\\:\\ 0\\.05541478344634921\ \(0\)\
\-\ demonstrating\\:\\ 0\\.05316188466302988\ \(0\)\
\-\ continued\\:\\ 0\\.05282648342684891\ \(0\)\
\-\ thrombosis\\:\\ 0\\.052565149420320034\ \(0\)\
\-\ resolution\\:\\ 0\\.05230972177560996\ \(0\)\
\-\ previously\\:\\ 0\\.05175527965921891\ \(0\)\
\-\ limits\\:\\ 0\\.05094349139998365\ \(0\)\
\-\ includes\\:\\ 0\\.05013391925687917\ \(0\)\
\-\ vessels\\:\\ 0\\.05003022869261062\ \(0\)\
\-\ removal\\:\\ 0\\.049281465402058494\ \(0\)\
\-\ tumors\\:\\ 0\\.047415702330100756\ \(0\)\
\-\ calcification\\:\\ 0\\.046030027317883554\ \(0\)\
\-\ chemotherapy\\:\\ 0\\.04577925523763368\ \(0\)\
\-\ kidney\\:\\ 0\\.04529381040297397\ \(0\)\
\-\ girl\\:\\ 0\\.04522613240296059\ \(0\)\
\-\ 30\\:\\ 0\\.04398147548181204\ \(0\)\
\-\ asymptomatic\\:\\ 0\\.04389117785984766\ \(0\)\
\-\ inferior\\:\\ 0\\.043861238260271815\ \(0\)\
\-\ areas\\:\\ 0\\.043771892401864264\ \(0\)\
\-\ possible\\:\\ 0\\.04368324730250029\ \(0\)\
\-\ size\\:\\ 0\\.04365385276777617\ \(0\)\
\-\ followed\\:\\ 0\\.04353703320342276\ \(0\)\
\-\ internal\\:\\ 0\\.04345020415487505\ \(0\)\
\-\ initial\\:\\ 0\\.0432501601320956\ \(0\)\
\-\ along\\:\\ 0\\.04319364905321051\ \(0\)\
\-\ study\\:\\ 0\\.04299805617281772\ \(0\)\
\-\ superior\\:\\ 0\\.04191580669348321\ \(0\)\
\-\ adjacent\\:\\ 0\\.04179064270966048\ \(0\)\
\-\ age\\:\\ 0\\.040476044860824414\ \(0\)\
\-\ decreased\\:\\ 0\\.03993516691007854\ \(0\)\
\-\ demonstrated\\:\\ 0\\.03962264398750801\ \(0\)\
\-\ evaluation\\:\\ 0\\.03931853078216863\ \(0\)\
\-\ lung\\:\\ 0\\.03921895135182745\ \(0\)\
\-\ month\\:\\ 0\\.03921895135182745\ \(0\)\
\-\ infection\\:\\ 0\\.038944707929582455\ \(0\)\
\-\ the\\:\\ 0\\.03859339071112366\ \(0\)\
\-\ carcinoma\\:\\ 0\\.03856412677942223\ \(0\)\
\-\ cell\\:\\ 0\\.036880849595589904\ \(0\)\
\-\ prior\\:\\ 0\\.03607209477474305\ \(0\)\
\-\ metastatic\\:\\ 0\\.0353595663743573\ \(0\)\
\-\ increased\\:\\ 0\\.034863292848063825\ \(0\)\
\-\ noted\\:\\ 0\\.03418286287504677\ \(0\)\
\-\ can\\:\\ 0\\.033832766983461174\ \(0\)\
\-\ case\\:\\ 0\\.032389939697844476\ \(0\)\
\-\ demonstrates\\:\\ 0\\.032389939697844476\ \(0\)\
\-\ large\\:\\ 0\\.03230358059779333\ \(0\)\
\-\ have\\:\\ 0\\.03220720888165552\ \(0\)\
\-\ after\\:\\ 0\\.03127633522040694\ \(0\)\
\-\ also\\:\\ 0\\.030325694914176318\ \(0\)\
\-\ within\\:\\ 0\\.029693730746534686\ \(0\)\
\-\ that\\:\\ 0\\.027978350705994703\ \(0\)\
\-\ by\\:\\ 0\\.027378472618875483\ \(0\)\
\-\ normal\\:\\ 0\\.02632341050601119\ \(0\)\
\-\ from\\:\\ 0\\.02560547231943084\ \(0\)\
\-\ with\\:\\ 0\\.02524877550008037\ \(0\)\
\-\ was\\:\\ 0\\.0224690664623756\ \(0\)\
\-\ or\\:\\ 0\\.022428597061636846\ \(0\)\
\-\ this\\:\\ 0\\.02215367730138323\ \(0\)\
\-\ old\\:\\ 0\\.019081064623814085\ \(0\)\
\-\ to\\:\\ 0\\.01611782756274717\ \(0\)\
\-\ in\\:\\ 0\\.016038495648864497\ \(0\)\
